Marshall Wace
BHVN

Marshall Wace’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,406
Closed -$2.93M 3653
2022
Q3
$2.93M Sell
19,406
-1,909,218
-99% -$289M 0.01% 1414
2022
Q2
$281M Sell
1,928,624
-472,660
-20% -$68.9M 0.58% 18
2022
Q1
$285M Sell
2,401,284
-397,173
-14% -$47.1M 0.54% 20
2021
Q4
$386M Buy
2,798,457
+80,272
+3% +$11.1M 0.71% 16
2021
Q3
$378M Sell
2,718,185
-14,183
-0.5% -$1.97M 1.57% 1
2021
Q2
$265M Sell
2,732,368
-44,099
-2% -$4.28M 1.2% 5
2021
Q1
$190M Buy
2,776,467
+219,915
+9% +$15M 0.87% 9
2020
Q4
$219M Buy
2,556,552
+28,702
+1% +$2.46M 1.19% 8
2020
Q3
$164M Buy
2,527,850
+26,406
+1% +$1.72M 1.05% 11
2020
Q2
$183M Sell
2,501,444
-61,999
-2% -$4.53M 1.28% 6
2020
Q1
$87.2M Buy
2,563,443
+2,312,881
+923% +$78.7M 0.87% 17
2019
Q4
$13.6M Sell
250,562
-287,235
-53% -$15.6M 0.09% 221
2019
Q3
$22.4M Buy
537,797
+251,836
+88% +$10.5M 0.18% 121
2019
Q2
$12.5M Buy
285,961
+278,863
+3,929% +$12.2M 0.1% 215
2019
Q1
$365K Buy
+7,098
New +$365K ﹤0.01% 1214